To the central content area :::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Chen, Wei-Jen Chen, Wei-Jen Jesse Wu (06)6323588 Building A, NO.154,Kai-Yuan Road,Hsin-Ying(730), Tainan, Taiwan 2016/09/26
Industry Main Business
Biotechnology and Medical Care SYNGEN BIOTECH Founded in April 1999, Syngen Biotech Co., Ltd is a fast-growing biotech company which specialized in strain identification, micro-organism fermentation, recovery and purification to improve people’s lives by providing the best quality of products such as active pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products. We strive to become a top tier global active pharmaceutical ingredient (APIs) manufacturer and an excellent supplier of dietary supplement in Taiwan.
Market Information ( 2023/06/02 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
18.452 184.50  181.50  184.00  0.50  28 N/A N/A
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N N N Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.